Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 10201-10212

  Zhu, Ren ^a,b,d   Mancini Bourgine, Maryline ^a,b   Zhang, Xiao Ming ^a   Bayard, Florence ^a,b   Deng, Qiang ^a,b,c   Michel, Marie Louise ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

^d TRANSGENE S A   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD11B ANTIGEN; CD27 ANTIGEN; DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; PLASMID VECTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CELL MATURATION; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFECT; HEPATITIS B; LIVER; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD27; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; IMMUNIZATION; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; MACROPHAGE-1 ANTIGEN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PLASMIDS; SPLEEN; VACCINES, DNA;

BACTERIA (MICROORGANISMS); HEPATITIS B VIRUS; MUS;

EID: 80054001242     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00062-11     Document Type: Article

References (56)

1. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294:15-22.
2. Andoniou, C. E., J. D. Coudert, and M. A. Degli-Esposti. 2008. Killers and beyond: NK-cell-mediated control of immune responses. Eur. J. Immunol. 38:2938-2942.
3. Babiuk, S., et al. 2004. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine. Immunology 113:114-120.
4. Bayard, F., S. Malmassari, Q. Deng, Y.-C. Lone, and M.-L. Michel. 2010. Hepatitis B virus (HBV)-derived DRB1*0101-restricted CD4 T-cell epitopes help in the development of HBV-specific CD8+ T cells in vivo. Vaccine 28:3818-3826.
5. Bihl, F., et al. 2010. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J. Immunol. 185:2174-2181.
6. Biron, C. A. 2010. Expansion, maintenance, and memory in NK and T cells during viral infections: responding to pressures for defense and regulation. PLoS Pathog. 6:e1000816.
7. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189-220.
8. Bonorino, P., et al. 2009. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J. Hepatol. 51:458-467.
9. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1:41-49.
10. Chiossone, L., et al. 2009. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113:5488-5496.
11. Cooper, M. A., T. A. Fehniger, and M. A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633-640.
12. De Colvenaer, V., et al. 2010. Continuous CD27 triggering in vivo strongly reduces NK cell numbers. Eur. J. Immunol. 40:1107-1117.
13. Di Santo, J. P. 2008. Functionally distinct NK-cell subsets: developmental origins and biological implications. Eur. J. Immunol. 38:2948-2951.
14. Dunn, C., et al. 2007. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204:667-680.
15. Dunn, C., et al. 2009. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137:1289-1300.
16. Fauriat, C., E. O. Long, H. G. Ljunggren, and Y. T. Bryceson. 2010. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115:2167-2176.
17. Fisicaro, P., et al. 2009. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58:974-982.
18. Haddad, E. A., L. K. Senger, and F. Takei. 2009. An accessory role for B cells in the IL-12-induced activation of resting mouse NK cells. J. Immunol. 183:3608-3615.
19. Hayakawa, Y., N. D. Huntington, S. L. Nutt, and M. J. Smyth. 2006. Functional subsets of mouse natural killer cells. Immunol. Rev. 214:47-55.
20. Hayakawa, Y., and M. J. Smyth. 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176:1517-1524.
21. Hayakawa, Y., and M. J. Smyth. 2006. NKG2D and cytotoxic effector function in tumor immune surveillance. Semin. Immunol. 18:176-185.
22. Hunter, C. A., K. E. Gabriel, T. Radzanowski, L. E. Neyer, and J. S. Remington. 1997. Type I interferons enhance production of IFN-gamma by NK cells. Immunol. Lett. 59:1-5.
23. Ishii, K. J., et al. 2008. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451:725-729.
24. Klinman, D. M. 2006. Adjuvant activity of CpG oligodeoxynucleotides. Int. Rev. Immunol. 25:135-154.
25. + central memory-type T cells in unimmunized mice as novel immunomodulator of IFN-γ-dependent type 1 immunity. Int. Immunol. 19:249-256.
26. Krebs, P., et al. 2009. NK cell-mediated killing of target cells triggers robust antigen-specific T cell-mediated and humoral responses. Blood 113:6593-6602.
27. Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359-393.
28. Lapaque, N., T. Walzer, S. Méresse, E. Vivier, and J. Trowsdale. 2009. Interactions between human NK cells and macrophages in response to Salmonella infection. J. Immunol. 182:4339-4348.
29. Loirat, D., F. A. Lemonnier, and M.-L. Michel. 2000. Multiepitopic HLAA*0201-restricted immune response against hepatitis B surface antigen after DNA-Based immunization. J. Immunol. 165:4748-4755.
30. Loirat, D., et al. 1999. Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses. Virology 260:74-83.
31. Lunemann, A., J. D. Lunemann, and C. Munz. 2009. Regulatory NK-cell functions in inflammation and autoimmunity. Mol. Med. 15:352-358.
32. Maini, M., K., and A. Schurich. 2010. The molecular basis of the failed immune response in chronic HBV: therapeutic implications. J. Hepatol. 52:616-619.
33. Malanchere-Bres, E., et al. 2001. CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice. J. Virol. 75:6482-6491.
34. Mancini, M., M. Hadchouel, P. Tiollais, and M. L. Michel. 1998. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization. J. Immunol. 161:5564-5570.
35. Mancini-Bourgine, M., et al. 2007. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virusinfected patients. J. Virol. 81:4963-4972.
36. Mancini-Bourgine, M., H. Fontaine, C. Brechot, S. Pol, and M. L. Michel. 2006. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers. Vaccine 24:4482-4489.
37. Mancini-Bourgine, M., et al. 2004. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology 40:874-882.
38. McCluskie, M. J., and A. M. Krieg. 2006. Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA. Curr. Top. Microbiol. Immunol. 311:155-178.
39. Michel, M. L., et al. 1995. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Natl. Acad. Sci. U. S. A. 92:5307-5311.
40. Milich, D., et al. 1990. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. I. T cell fine specificity. J. Immunol. 144:3535-3543.
41. Moretta, A., E. Marcenaro, S. Parolini, G. Ferlazzo, and L. Moretta. 2008. NK cells at the interface between innate and adaptive immunity. Cell Death Differ. 15:226-233.
42. Nishikado, H., K. Mukai, Y. Kawano, Y. Minegishi, and H. Karasuyama. 2011. NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo. J. Immunol. 186:5766-5771.
43. Oliviero, B., et al. 2009. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137: 1151-1160.
44. Renard, V., et al. 1995. Normal development and function of natural killer cells in CD3 epsilon delta 5/delta 5 mutant mice. Proc. Natl. Acad. Sci. U. S. A. 92:7545-7549.
45. Rottembourg, D., et al. 2010. Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection. J. Immunol. 184:7100-7107.
46. Sato, Y., et al. 1996. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354.
47. Schirmbeck, R., W. Böhm, N. Fissolo, K. Melber, and J. Reimann. 2003. Different immunogenicity of H-2Kb-restricted epitopes in natural variants of the hepatitis B surface antigen. Eur. J. Immunol. 33:2429-2438.
48. Scott-Algara, D., M. Mancini-Bourgine, H. Fontaine, S. Pol, and M.-L. Michel. 2010. Changes to the natural killer cell repertoire after therapeutic hepatitis B DNA vaccination. PLoS One 5:e8761.
49. Spies, B., et al. 2003. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J. Immunol. 171:5908-5912.
50. Swann, J. B., et al. 2007. Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J. Immunol. 178:7540-7549.
51. Vahlne, G., S. Becker, P. Brodin, and M. H. Johansson. 2008. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells. Scand. J. Immunol. 67:1-11.
52. Walzer, T., et al. 2007. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. U. S. A. 104:3384-3389.
53. Yan, M. X., H. T. Mao, Q. Liu, W. Q. Wang, and Y. Q. Li. 2006. Elevated levels of serum soluble E-selectin in patients with chronic hepatitis B: correlation with T lymphocyte subsets, NK cells and liver inflammation. Hepatol. Res. 35:111-117.
54. Yoshida, O., et al. 2008. Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: restoration of adaptive immunity in natural killer-depleted mice by antigenpulsed dendritic cell. Clin. Exp. Immunol. 152:174-181.
55. Yu, J., et al. 2010. CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood 115: 274-281.
56. Zhu, R., et al. 2007. The pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis. J. Immunol. 178:5435-5442.